Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis.
Saved in:
| Title: | Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis. |
|---|---|
| Authors: | Ma, Yuxi1,2,3 (AUTHOR), Li, Yuting1,2,3 (AUTHOR), Lin, Zhenyu1,2,3 (AUTHOR), Wang, Jing1,2,3 (AUTHOR), Hu, Jianli1,2,3 (AUTHOR), Liu, Hongli1,2,3 (AUTHOR), Yang, Yali1,2,3 (AUTHOR), Liu, Junli1,2,3 (AUTHOR) junli78@foxmail.com, Zhang, Tao1,2,3 (AUTHOR) taozhangxh@hust.edu.cn |
| Source: | BMC Cancer. 6/6/2025, Vol. 25 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-025-14206-9 |
